CS/HB 1567 — Insulin Administration by Direct Support Professionals and Relatives
by Human Services Subcommittee and Rep. Tuck and others (CS/CS/SB 1736 by Appropriations Committee on Health and Human Services; Children, Families, and Elder Affairs Committee; and Senators Grall, Sharief, and Bradley)
This summary is provided for information only and does not represent the opinion of any Senator, Senate Officer, or Senate Office.
Prepared by: Children, Families, and Elder Affairs Committee (CF)
The bill creates a new section of law to allow a direct-support professional or the relative of an individual in an Agency for Persons with Disabilities licensed group home facility to administer insulin to a client with a developmental disability. The bill provides that the administration of insulin includes sliding scale insulin therapy, to include the calculation of an insulin dose based on current blood glucose and the administration of that calculated dose subcutaneously using an insulin pen containing premeasured doses or a syringe filled with the calculated dose drawn from a vial of insulin.
The bill defines the term “direct-support professional” to mean an individual paid to provide services directly to a client with developmental disabilities that receives home and community-based services.
The bill allows direct-support professionals or relatives to administer insulin to individuals if the group home facility provides training and adopts policies and procedures governing the administration of insulin by direct-support professionals or relatives.
The bill further provides immunity from civil liability to group home facilities that are compliant with the requirements for the administration of insulin. The bill provides civil and criminal immunity to direct-support professionals or relatives for the administration of insulin in group home facilities, so long as the direct-support professional or relative were compliant with the requirements of administration.
The bill also adds subcutaneous administration of insulin and epinephrine by self-administration devices to existing medication administration law that allows an unlicensed direct service provider to administer or supervise the self-administration of certain medications.
If approved by the Governor, or allowed to become law without the Governor’s signature, these provisions take effect July 1, 2025.
Vote: Senate 38-0; House 111-0